Skip to content

Graham Reed Ellington

NPI 1730648015ActiveIndividual· Internal Medicine, Pulmonary Disease· Tyler, TX

Internal Medicine, Pulmonary Disease in Tyler, Texas, licensed in TX, with an NPI issued in March 2019. Part D covered 76 prescriptions written in 2024, 49% of them generic. Boehringer Ingelheim Pharmaceuticals, Inc. reported $16.19 in payments in 2025, mostly food and beverage.

Overview

NPI1730648015
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 17, 2019
Last updated in NPPESAug 13, 2026
Certified by providerAug 13, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hospitalist (TX)

Part D prescriptions in 2024

Prescriptions (claims)76 · 107 30-day fills
Patients20
Total drug cost$14,733
Generic share49% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$16.19 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Boehringer Ingelheim Pharmaceuticals, Inc.$16.191

What the 2025 payments were for

  • Food and Beverage$16.19 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Tyler

All Internal Medicine, Pulmonary Disease providers in Texas →